More on DXR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.5 Score)
- Dividends (0.3% Yield)

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/19/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Daxor Corp. (NQ:DXR)
Delayed: 11.38 -0.07 (0.61%)
Prev. Close $11.45  
Open$11.26 
52 Wk High$8.90 
52 Wk Low$7.00 
Day High$11.40 
Day Low$11.15 
P/E N/A  
EPS$-1.70 
Volume6,159 

Friends, Peers and Foes (?): ARDT (more...)

Mar 3, 2026 08:32 AM Daxor reports 45% revenue growth, plans regulatory shift to Exchange Act
Mar 3, 2026 08:32 AM Daxor reports 45% revenue growth, plans regulatory shift to Exchange Act
Mar 3, 2026 08:30 AM Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Mar 3, 2026 08:00 AM Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
Mar 2, 2026 04:37 PM Form N-CSR DAXOR CORP For: Dec 31
Mar 2, 2026 04:20 PM Form NPORT-P DAXOR CORP For: Dec 31
Feb 24, 2026 08:06 AM Daxor launches blood volume diagnostic program in Tennessee
Feb 24, 2026 08:00 AM Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
Feb 11, 2026 08:22 AM Lake Street Capital Markets Starts Daxor Corp. (DXR) at Buy
Feb 10, 2026 08:04 AM Daxor transitions to Exchange Act reporting framework
View All Articles

Entities mentioned with DXR

View All Entities